Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Market Insight - UCL Business tackling pharma's university challenge

This article was originally published in Scrip

Executive Summary

The pharmaceutical industry's productivity crisis is forcing companies to look further upstream for opportunities to tie up early-stage IP. For many firms this means doing deals on leading universities' territory. Academic institutions are learning to leverage their relationships with pharma as well. UCL Business, a wholly owned subsidiary of University College London, is doing deals to bring university assets closer to market with one ultimate goal: to deliver patient benefit, discovers Pete Chan.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts